These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38118015)
1. Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA). Holm M; MacWright WR; Poudyal N; Shaw AG; Joh HS; Gallagher PF; Kim JH; Shaikh AT; Seo HJ; Kwon SY; Prifti K; Dolabella B; Taylor BEW; Yeats C; Aanensen DM; Stelling J; Marks F Clin Infect Dis; 2023 Dec; 77(Suppl 7):S500-S506. PubMed ID: 38118015 [TBL] [Abstract][Full Text] [Related]
2. CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual). Joh HS; Dolabella B; Early E; Stelling J; Ak G; Upadhyaya MK; Rahman A; Chuki P; MacWright WR; Ondoa P; Sarkar S; Moore C; Holm M; Leslie T; Zellweger RM; Paing G; Kwon SY; Marks F; Poudyal N Clin Infect Dis; 2023 Dec; 77(Suppl 7):S536-S542. PubMed ID: 38118006 [TBL] [Abstract][Full Text] [Related]
3. Effective Stakeholder Engagement for Collation, Analysis and Expansion of Antimicrobial Resistance (AMR) Data: A CAPTURA Experience. Poudyal N; Holm M; Joh HS; Gautam S; Sujan MJ; Kwon SY; Sahikh A; Shaw A; Gallagher P; Prifti K; Cho A; Chi KK; Aboushady AT; MacWright WR; Stelling J; Marks F Clin Infect Dis; 2023 Dec; 77(Suppl 7):S519-S527. PubMed ID: 38118005 [TBL] [Abstract][Full Text] [Related]
4. Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening. Joh HS; Yeats C; Shaw A; Poudyal N; Gallagher P; Kim JH; Shaikh A; Seo HJ; Chi KK; Prifti K; Cho A; Sujan MJ; Eraly E; Pham KD; Shrestha S; Aboushady AT; Pak G; Jang G; Park EL; Seo HW; Abudahab K; Taylor BEW; Clark A; Dolabella B; Yoon H; Han J; Kwon SY; Marks F; Stelling J; Aanensen DM; MacWright WR; Holm M Clin Infect Dis; 2023 Dec; 77(Suppl 7):S507-S518. PubMed ID: 38118007 [TBL] [Abstract][Full Text] [Related]
5. The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The CAPTURA Experience. Leslie T; Parry C; Ondoa P; Walsh T; Moore C; Poudyal N; Marks F; Gordon NC Clin Infect Dis; 2023 Dec; 77(Suppl 7):S497-S499. PubMed ID: 38118008 [TBL] [Abstract][Full Text] [Related]
6. Key Recommendations for Antimicrobial Resistance Surveillance: Takeaways From the CAPTURA Project. Aboushady AT; Sujan MJ; Pham K; Clark A; Marks F; Holm M; Joh HS; Poudyal N; Stelling J Clin Infect Dis; 2023 Dec; 77(Suppl 7):S581-S587. PubMed ID: 38118016 [TBL] [Abstract][Full Text] [Related]
7. Recording and Reporting of Antimicrobial Resistance (AMR) Priority Variables and Its Implication on Expanding Surveillance Sites in Nepal: A CAPTURA Experience. Maharjan S; Gallagher P; Gautam M; Joh HS; Sujan MJ; Aboushady AT; Kwon SY; Gautam S; Upadhyaya MK; Jha R; Acharya J; MacWright WR; Marks F; Stelling J; Poudyal N Clin Infect Dis; 2023 Dec; 77(Suppl 7):S560-S568. PubMed ID: 38118014 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Resistance Surveillance Methods in Bangladesh: Present and Way Forward. Sujan MJ; Habib ZH; Rahman A; Rizvi SMS; Barua HT; Aboushady AT; Hasnat MA; Rasul SBG; Joh HS; Prifti K; Chi KK; Kwon SY; Clark A; Gautam S; Holm M; Marks F; Stelling J; Shaw A; Poudyal N Clin Infect Dis; 2023 Dec; 77(Suppl 7):S549-S559. PubMed ID: 38118018 [TBL] [Abstract][Full Text] [Related]
10. Utility and Evaluation of Applied Project Management Processes Within a Large Multicountry Health Systems Development Project Conducted During the Coronavirus Disease 2019 (COVID-19) Pandemic. Kwon SY; Gautam S; Poudel K; Banneheke H; Ferreira D; Gautam M; Hau'ofa M; Mahmood N; Phommalad B; Sujan MJ; Yangzom P; Joh HS; Shaw A; Dolabella B; Seo HJ; Kim JH; Gallagher P; MacWright WR; Poudyal N; Marks F; Holm M Clin Infect Dis; 2023 Dec; 77(Suppl 7):S543-S548. PubMed ID: 38118010 [TBL] [Abstract][Full Text] [Related]
11. Surveillance of antimicrobial resistance in the United Arab Emirates: the early implementation phase. Thomsen J; Abdulrazzaq NM; AlRand H; Front Public Health; 2023; 11():1247627. PubMed ID: 38074700 [TBL] [Abstract][Full Text] [Related]
12. Identifying and addressing challenges to antimicrobial use surveillance in the human health sector in low- and middle-income countries: experiences and lessons learned from Tanzania and Uganda. Kiggundu R; Lusaya E; Seni J; Waswa JP; Kakooza F; Tjipura D; Kikule K; Muiva C; Joshi MP; Stergachis A; Kitutu FE; Konduri N Antimicrob Resist Infect Control; 2023 Feb; 12(1):9. PubMed ID: 36759872 [TBL] [Abstract][Full Text] [Related]
13. Collecting Multi-country Retrospective Antimicrobial Consumption and Use Data: Challenges and Experience. Prifti K; Chi KK; Eraly E; Joh HS; Sujan MJ; Poudyal N; Marks F; Holm M Clin Infect Dis; 2023 Dec; 77(Suppl 7):S528-S535. PubMed ID: 38118011 [TBL] [Abstract][Full Text] [Related]
14. Characterisation and mapping of the surveillance system for antimicrobial resistance and antimicrobial use in the United Kingdom. Bennani H; Cornelsen L; Stärk KDC; Häsler B Vet Rec; 2021 Apr; 188(7):e10. PubMed ID: 33835538 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries. Gandra S; Alvarez-Uria G; Turner P; Joshi J; Limmathurotsakul D; van Doorn HR Clin Microbiol Rev; 2020 Sep; 33(3):. PubMed ID: 32522747 [TBL] [Abstract][Full Text] [Related]
16. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia. Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance patterns in bacteria causing febrile illness in Africa, South Asia, and Southeast Asia: a systematic review of published etiological studies from 1980-2015. Roberts T; Dahal P; Shrestha P; Schilling W; Shrestha R; Ngu R; Huong VTL; van Doorn HR; Phimolsarnnousith V; Miliya T; Crump JA; Bell D; Newton PN; Dittrich S; Hopkins H; Stepniewska K; Guerin PJ; Ashley EA; Turner P Int J Infect Dis; 2022 Sep; 122():612-621. PubMed ID: 35817284 [TBL] [Abstract][Full Text] [Related]
18. Integrated surveillance of antimicrobial resistance and antimicrobial use: Evaluation of the status in Canada (2014-2019). Otto SJG; Haworth-Brockman M; Miazga-Rodriguez M; Wierzbowski A; Saxinger LM Can J Public Health; 2022 Feb; 113(1):11-22. PubMed ID: 35099780 [TBL] [Abstract][Full Text] [Related]
19. One Health Surveillance of Antimicrobial Use and Resistance: Challenges and Successes of Implementing Surveillance Programs in Sri Lanka. Ariyawansa S; Gunawardana KN; Hapudeniya MM; Manelgamage NJ; Karunarathne CR; Madalagama RP; Ubeyratne KH; Wickramasinghe D; Tun HM; Wu P; Lam TTY; Chan OSK Antibiotics (Basel); 2023 Feb; 12(3):. PubMed ID: 36978313 [TBL] [Abstract][Full Text] [Related]
20. Integrated surveillance of antimicrobial resistance and antimicrobial use: Evaluation of the status in Canada (2014-2019). Otto SJG; Haworth-Brockman M; Miazga-Rodriguez M; Wierzbowski A; Saxinger LM Can Vet J; 2022 Feb; 63(2):161-170. PubMed ID: 35110774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]